In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Signum Biosciences, Inc

Latest From Signum Biosciences, Inc

Deals Shaping The Medical Industry (01/2012)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Dr Braham Shroot joins Signum Biosciences

The private US biotechnology company Signum Biosciences has appointed Dr Braham Shroot, formerly chief scientific officer of Barrier Therapeutics, as CEO. Dr Shroot succeeds Dr Gregory Stock, who will continue with the company as a member of the board.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals